Assoc. Prof Michael is a Gastrointestinal (GI) and Neuroendocrine Medical Oncologist at the Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre: Clinical and Trial Lead Upper Gastrointestinal Medical Oncology Service, & Co-Chair of the Neuroendocrine Tumour Unit. Associate Professor, Faculty of Medicine and Health Sciences, The University of Melbourne. He co-chairs the PeterMac Neuroendocrine Unit- with a national/international referral base and helped establish the first national NET Clinic at his institution and the development of post-graduate training courses in this area. The Neuroendocrine Unit is this first centre to be certified as a European Neuroendocrine Tumour Society Centre of Excellence, outside of Europe. The care of neuroendocrine tumour (NETS) patients represents 50% of his clinical load, which represents the largest national practises in this oncology subspecialty. Current member of ASCO, ENETs, AGITG, COMNETS and MOGA He has significant research interests/expertise in combined modality therapies for GI malignancies especially NETs, with a particular focus on combined modality therapies, the evaluation of novel systemic agents and development of dynamic biomarkers in this disease. He has been site investigator on a number of phase I-III trials in NETs and CI on a translational research grant in the area, as well medical lead on nutritional and behavioural medicine trials in NETs. He has supervised PhD and post-doctoral students in translational and clinical studies in GI and NET oncology.